Abstract:Background: Obesity and hypertension are major risk factors for cardiovascular diseases that affect millions of people worldwide. Both conditions are associated with chronic low-grade inflammation, which is mediated by adipokines such as adiponectin. Adiponectin is the most abundant adipokine that has a beneficial impact on metabolic and vascular biology, while high serum concentrations are associated with some syndromes. This "adiponectin paradox" still needs to be clarified in obesity-associated hypertension. The aim of this study was to investigate how adiponectin affects blood pressure, inflammation, and metabolic function in obesity hypertension using a Chinese adult case-control study. Methods: A case-control study that had finished recruiting 153 subjects divided as four characteristic groups. Adiponectin serum levels were tested by ELISA in these subjects among these four characteristic Chinese adult physical examination groups. Waist circumference (WC), body mass index (BMI), systolic blood pressure (SB), diastolic blood pressure (DB), and other clinical laboratory data were collected. Analyzation of correlations between the research index and differences between groups was done by SPSS. Results: Serum adiponectin levels in the| normal healthy group (NH group) were significantly higher than those in the newly diagnosed untreated just-obesity group (JO group), and negatively correlated with the visceral adiposity index. With multiple linear egression analysis, it was found that, for serum adiponectin, gender, serum albumin (ALB), alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDLC) were the significant independent correlates, and for SB, age and HDLC were the significant independent correlates, and for DB, alkaline phosphatase (ALP) was the significant independent correlate. The other variables did not reach significance in the model. Conclusions: Our study reveals that adiponectin's role in obesity-hypertension is multifaceted and is influenced by the systemic metabolic homeostasis signaling axis. In obesity-related hypertension, compensatory effects, adiponectin resistance, and reduced adiponectin clearance from impaired kidneys and liver all contribute to the "adiponectin paradox".

Adiponectin Is A Useful Biomarker During Transition From Hypertension To Onset Of Heart Dysfunction

Adiponectin Through Its Biphasic Serum Level is a Useful Biomarker During Transition from Diastolic Dysfunction to Systolic Dysfunction

Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study

First-phase Ejection Fraction to Predict Adverse Outcomes in Patients with Heart Failure.

Clinical Significance of the Changes of Plasma Adiponectin Levels in Patients with Coronary Artery Disease

Adiponectin is Valuable in the Diagnosis of Acute Heart Failure with Renal Insufficiency.

Is Adiponectin Elevation Associated with Left Atrial Remodeling and Impaired Mechanical Functions? (a Speckle Tracking Study)

Adropin – A New Player in Energy Regulation Predicts Long-Term Prognosis of Patients with Acute Myocardial Infarction

Advances in Research into Relationship Between Adipose Tissue and Chronic Heart Failure

Adiponectin Deficiency Accentuates High Fat Diet‐Induced Cardiac Hypertrophy and Contractile Dysfunction Through Regulation of Autophagy

Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides

Long-Term Prognostic Value of Adipocytokines in Patients with Acute Coronary Syndrome: An 8-Year Clinical Prospective Cohort Study

Changes of Plasma Adrenomedullin and Proadrenomedullin N-terminal 20 Peptide Concentrations in Patients with Heart Failure.

Relationship of Adiponectin in Plasma to Brain Natriuretic Peptide and Left Ventricular Mass Index of Patients with Chronic Heart Failure

Plasma Adiponectin Levels in Obese Patients with Essential Hypertension and Its Affecting Factors

Reevaluating Adiponectin's impact on obesity hypertension: a Chinese case-control study

Adiponectin Protects Rat Myocardium against Chronic Intermittent Hypoxia-Induced Injury via Inhibition of Endoplasmic Reticulum Stress

Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta Constriction

Adiponectin Improves Cardiomyocyte Contractile Function In Db/Db Diabetic Obese Mice

Can Adiponectin Help us to Target Diastolic Dysfunction?

Surgical tattooing for port wine stain.